| Product Name | MF | CAS | Details |
|---|
| Rottlerin | C30H28O8 | 82-08-6 | Details |
| 1-Methyl-4,5,6,7-tetrahydro-1H-1,2,3-benzotriazole-6-carboxylic acid | C8H11N3O2 | 1496734-87-2 | Details |
| phrB protein (His tag) | Details |
| Diethyldithiocarbamic acid silver salt | C5H10AgNS2 | 1470-61-7 | Details |
| N-alpha-Z-L-ornithine | C13H18N2O4 | 2640-58-6 | Details |
| FBPA antibody | Details |
| METT10D Blocking Peptide | Details |
| 2-Phenoxyethane-1-sulfonamide | C8H11NO3S | 100383-38-8 | Details |
| H-Gly-Arg-Gly-Asp-Asn-Pro-OH | C23H38N10O10 | 114681-65-1 | Details |
| Chlorhexidine dihydrochloride impurity B | C16H26ClN9O | 1308292-89-8 | Details |
| 4H-Thieno[3,2-B]pyrrole-2-carboxylic Acid | C7H5NO2S | 1007386-84-6 | Details |
| 4-[(5-Ethyl-1,2,4-oxadiazol-3-yl)methoxy]benzoic acid | C12H12N2O4 | 1274122-56-3 | Details |
| OLC1 antibody | Details |
| 3,4,6-Tri-O-acetyl-1,2-O-ethylidene-b-D-mannopyranose | Details |
| 5-[4-(2H-Tetrazol-5-yl)phenyl]-2H-tetrazole | C8H6N8 | 6926-49-4 | Details |
| 4,5,6,7-Tetrahydro-1,2-benzoxazol-3-amine | C7H10N2O | 1004-64-4 | Details |
| N-Carbamoyl-N'-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine | C10H17N6OS | 52568-80-6 | Details |
| Tiglyl glycine | C7H11NO3 | 35842-45-6 | Details |
| 1-(Oxolan-3-yl)propan-2-ol | C7H14O2 | 1503525-13-0 | Details |
| 4,5-Dimethoxyindole | C10H11NO2 | 30933-67-6 | Details |
| 4-(Oxolan-3-yl)phenol | C10H12O2 | 66123-37-3 | Details |
| JAK3-IN-6 | C19H18N4O3 | 1443235-95-7 | Details |
| [Phe7] Dynorphin A (1-7), amide, porcine | C43H59N11O8 | Details |
| 3-Chloro-4-methylaniline | C7H8ClN | 95-74-9 | Details |
| Flutamide | C11H11F3N2O3 | 13311-84-7 | Details |
| Bexarotene-13C4 Methyl Ester | C25H30O2 | 153559-48-9 | Details |
| Luteolin-7-O-D-glucopyranoside | C21H20O11 | 5373-11-5 | Details |
| TIM1 antibody (biotin) | Details |
| 3-Amino-1-(3-ethynylphenyl)thiourea | C9H9N3S | 1071638-49-7 | Details |
| 4-(Methylsulfonyl)phenylhydrazine hydrochloride | C7H11ClN2O2S | 17852-67-4 | Details |
| N-Methyl-o-toluidine | C8H11N | 611-21-2 | Details |
| [1-(Oxolan-3-yl)-1H-1,2,3-triazol-4-yl]methanol | C7H11N3O2 | 1342544-21-1 | Details |
| 2-Iodo-4-methoxybenzaldehyde | C8H7IO2 | 105469-13-4 | Details |
| N-(2-Aminoethyl)-4-bromobenzamide | C9H11BrN2O | 152535-04-1 | Details |
| 2-Methyl-5,6,7,8-tetrahydroquinazolin-5-amine | C9H13N3 | 927803-66-5 | Details |
| WRAP53 antibody | Details |
| Hydrotalcite | CAlO9(-5) | 12304-65-3 | Details |
| Methyl 6-hydroxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate hydrochloride | 2228465-53-8 | Details |
| 1-(2-(4-trifluoromethoxyphenoxy)acetyl)-4-(2-chlorophenyl)semicarbazide | C16H13ClF3N3O4 | 1022454-89-2 | Details |
| 2-(Thiophen-2-yl)-1H-1,3-benzodiazole-6-carbonitrile | C12H7N3S | 1421261-89-3 | Details |
| (3,5-Diiodo-Tyr1,D-Ala2,N-Me-Phe4,glycinol5)-Enkephalin acetate salt | C26H33I2N5O6 | 103213-42-9 | Details |
| Recombinant Human SCGF-beta | Details |
| Direct yellow PG | C13H14N3NaO4S | 6300-07-8 | Details |
| o-Desphenyl sofosbuvir | C16H25FN3O9P | 1233335-82-4 | Details |
| Methyl 2-fluoro-4-hydroxybenzoate | C8H7FO3 | 197507-22-5 | Details |
| R 715 | C57H81N13O12 | 185052-09-9 | Details |
| 5-(Ethoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | C17H18N2O6 | 74936-73-5 | Details |
| Mosapride citrate - Bio-X ? | C27H33ClFN3O10 | 112885-42-4 | Details |
| 2,4-Difluoro-3-methylbenzaldehyde | C8H6F2O | 847502-88-9 | Details |
| 1-(4-Methylpyrimidin-2-yl)-1H-pyrazol-3-amine | C8H9N5 | 1343861-23-3 | Details |
| 4-(3-Methylphenoxy)butanoic acid | C11H14O3 | 22180-01-4 | Details |
| RAB22A antibody | Details |
| 3,4,5-Trichloropicolinonitrile | C6HCl3N2 | 139485-42-0 | Details |
| Cytarabine | C9H13N3O5 | 147-94-4 | Details |
| 1-(2-Thiazolylazo)-2-naphthol | C13H9N3OS | 1147-56-4 | Details |
| 5,5-Dimethylspiro[2.3]hexan-1-amine hydrochloride | C8H16ClN | 2253640-65-0 | Details |
| Methyl 2-chloro-6-(trifluoromethyl)isonicotinate | C8H5ClF3NO2 | 1227594-40-2 | Details |
| 2-Chloro-1-{1-[3-(trifluoromethyl)phenyl]-1H-1,2,3-triazol-4-yl}ethan-1-one | C11H7ClF3N3O | 1384431-14-4 | Details |
| 1-(1,2,3,4-Tetrahydroisoquinolin-2-yl)ethan-1-one | C11H13NO | 14028-67-2 | Details |
| Nbi 27914 hydrochloride | C18H20Cl4N4.ClH | 1215766-76-9 | Details |
| 1-(7-Amino-2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one | C10H11NO3 | 164526-13-0 | Details |
| Pramipexole EP Impurity C | C20H32N6S2 | 1973461-14-1 | Details |
| 3-Fluoro-4-methoxybenzamide | C8H8FNO2 | 701640-04-2 | Details |
| 2-Chloroethyl methanesulfonylmethanesulfonate | C4H9ClO5S2 | 88343-72-0 | Details |
| RANTES antibody | Details |
| 1-(2-Aminopropoxy)-4-fluorobenzene | C9H12FNO | 93750-33-5 | Details |
| H-FAQSIPK-OH | Details |
| (3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)-N-(methyl((phenylamino)thioxomethyl)amino)formamide | C19H16Cl2N4O2S | 1023578-37-1 | Details |
| rac-tert-Butyl N-{[(1R,4R)-4-(bromomethyl)cyclohexyl]methyl}carbamate | C13H24BrNO2 | 198895-53-3 | Details |
| AS 19 | C18H25N3 | 1000578-26-6 | Details |
| N,5-Dimethyl-1,3-thiazol-2-amine hydrochloride | C5H9ClN2S | 2243507-93-7 | Details |
| 2-Bromo-1-(2-ethylphenyl)ethan-1-one | C10H11BrO | 593270-22-5 | Details |
| 3-Benzylpyrrolidine-2,5-dione | C11H11NO2 | 66195-04-8 | Details |
| UTY Blocking Peptide | Details |
| CSN3 Blocking Peptide | Details |
| 3-Chloro-2,2-dimethyl-1-(4-phenylpiperazin-1-yl)propan-1-one | C15H21ClN2O | 1211489-57-4 | Details |
| Chlorhexidine digluconate EP Impurity L | Details |
| 1-(2-Chloro-4-nitrophenyl)-1h-pyrrole-2-carbaldehyde | C11H7ClN2O3 | 881041-26-5 | Details |
| 3-((4-chlorophenyl)imino)indolin-2-one | C14H9ClN2O | 57644-24-3 | Details |
| Sodium 3-(4-chlorophenyl)-3-oxoprop-1-en-1-olate | C9H8ClNaO2 | 40160-35-8 | Details |
| [1-(2-Bromophenyl)cyclohexyl]methanamine hydrochloride | C13H19BrClN | 1864073-45-9 | Details |
| N-[4-Amino-3-(trifluoromethyl)phenyl]-4-fluorobenzamide | C14H10F4N2O | 926253-90-9 | Details |
| 2,3-Dihydro-3-oxo-5-isothiazolecarboxylic acid | C4H3NO3S | 1257444-26-0 | Details |
| Methyl 6-amino-3-methylpyridine-2-carboxylate | C8H10N2O2 | 1319069-28-7 | Details |
| 1-(Furan-2-yl)-2-methoxyethan-1-amine | C7H11NO2 | 186029-07-2 | Details |
| STARD4 Blocking Peptide | Details |
| H-PHCVPRDLSWLDLEANMCLP-OH | Details |
| 1'-(tert-Butoxycarbonyl)-[1,4'-bipiperidine]-4-carboxylic acid | C16H28N2O4 | 201810-59-5 | Details |
| 4-(Chloromethyl)-3-ethyl-5-methyl-1,2-oxazole | C7H10ClNO | 40500-39-8 | Details |
| Cathepsin F antibody (FITC) | Details |
| (2R)-1-Methyl-2-phenylaziridine | C9H11N | 1361410-99-2 | Details |
| CSK substrate | Details |
| Esculeogenin A | C27H45NO4 | 854381-37-6 | Details |
| 5-Methylfuran-2-carbothioamide | C6H7NOS | 1093076-67-5 | Details |
| 3-(Methoxymethyl)-1-methyl-1H-pyrazole-4-sulfonyl chloride | C6H9ClN2O3S | 1564710-51-5 | Details |
| 2-Methylpyrrolidine-1-sulfonyl chloride | C5H10ClNO2S | 1184477-87-9 | Details |
| Toremifene-d6 citrate | C32H30ClD6NO8 | 1246833-71-5 | Details |
| 2-(3-{Hexahydro-1H-pyrrolo[2,1-c]morpholin-3-yl}-1H-1,2,4-triazol-5-yl)ethan-1-amine dihydrochloride | C11H20ClN5O | 1803570-82-2 | Details |
| 5-Oxo-4H,5H,6H,7H,8H-furo[3,2-b]azepine-3-carboxylic acid | C9H9NO4 | 180340-64-1 | Details |
| 5-(Aminomethyl)-2,3-dihydro-1H-inden-1-one hydrochloride | 2172488-42-3 | Details |
| Product Total： Product Page： | ||||
| 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 | ||||